EGFR and central nervous system cancer: These findings suggested that YY1 functions as a positive regulator of GBP1 expression in the EGFRvIII expressing glioma cells–in surprising contrast to our previous finding that YY1 plays a suppressive role in mediating the effects of wild-type EGFR on GBP1 expression.